Forrester Research, Inc.
8.35-0.51 (-5.76%)
Oct 29, 4:00:01 PM EDT · NasdaqGS · FORR · USD
Key Stats
Market Cap
159.34MP/E (TTM)
-Basic EPS (TTM)
-4.67Dividend Yield
0%Recent Filings
10-Q
Q2 FY2025 results
Forrester's Q2 revenues fell 8% year-over-year to $111.7M, with Research down 7% to $77.9M and Events plunging 23% to $10.2M, yet operating income held at $7.0M, down just 39% from $11.3M as cost controls bit deep. Gross margins improved to 55.5% from 58.0%, while the YTD picture sours with a $83.9M goodwill impairment slamming net loss to $83.4M and diluted EPS to -$4.39 on 19.0M shares—anti-dilution kept shares flat. Cash from operations surged to $23.1M YTD, bolstering $67.8M in cash equivalents against $35.0M debt at 5.68% under a $150M revolver with $114.3M available and no covenant breaches. Restructuring trimmed headcount by 6% in January 2025, aiding efficiency. Wallet retention slipped to 85%. Sustained stock price drops could trigger more impairments.
8-K
Q2 revenues decline 8%
Forrester Research reported Q2 2025 revenues of $111.7 million, down from $121.8 million last year, amid persistent market uncertainty hitting contract value at $288.7 million, a 7% drop. Yet adjusted EPS held at $0.51, beating expectations through cost controls and AI enhancements like Izola. Full-year guidance projects revenues of $400-410 million and adjusted EPS of $1.20-1.35. Macro pressures linger.
8-K
Annual meeting elects board
Forrester Research stockholders at the May 13, 2025 annual meeting elected six directors—Robert Bennett, Neil Bradford, George F. Colony, Anthony Friscia, Corinne Munchbach, and Warren Romine—to the board, with strong support exceeding 90% for most nominees despite some withheld votes. They ratified PricewaterhouseCoopers LLP as auditors for the fiscal year ending December 31, 2025, with 18.1 million votes in favor and minimal opposition. The non-binding approval of executive compensation passed handily, signaling investor alignment. All directors won decisively.
10-Q
Q1 FY2025 results
Forrester Research posted Q1 FY2025 revenue of $89.9M, down 10% y/y from $100.1M, with research at $68.4M (off 11%) and consulting at $21.4M (down 7%), while events contributed a negligible $26K. Gross margins held steady around 56%, but operating expenses ballooned to $177.5M from $109.4M, driven by an $83.9M goodwill impairment in the research unit, yielding an operating loss of $87.6M versus $9.3M last year; net loss hit $87.3M or $4.62 per diluted share on 18.9M shares, with the impairment's non-deductibility shrinking the tax benefit to 1.2%. Cash from operations surged to $26.7M from $0.6M, boosting cash and equivalents to $75.6M alongside $58.7M in marketable investments, while $35M in debt carries a 5.68% effective rate under a $150M facility with $114M available and no covenant issues. Restructuring trimmed headcount by 6% in January, aligning costs amid softer bookings. That impairment stings, but cash flow proves resilient.
8-K
Q1 revenues drop amid impairment
Forrester Research reported Q1 2025 revenues of $89.9 million, down from $100.1 million last year, hammered by a $83.9 million goodwill impairment that flipped GAAP net income to a $87.3 million loss. Yet adjusted net income held at $2.0 million, with contract value slipping 7% to $290.9 million amid volatility. Cash flow surged to $26.7 million. The company sticks to full-year guidance of $400-415 million in revenue.
IPO
Website
Employees
Sector
Industry
CRAI
CRA International,Inc.
178.20-4.64
FCN
FTI Consulting, Inc.
168.78-1.29
FDS
FactSet Research Systems Inc.
266.89-21.51
FORA
Forian Inc.
2.33-0.02
HURN
Huron Consulting Group Inc.
169.61+17.13
ICFI
ICF International, Inc.
85.59-2.55
IT
Gartner, Inc.
249.74-2.96
KFY
Korn Ferry
66.50-3.81
NRC
National Research Corporation
13.45+0.20
VRSK
Verisk Analytics, Inc.
208.00-24.13